BlackRock, Inc. 13D and 13G filings for Day One Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | Day One Biopharmaceuticals, Inc. DAWN | BlackRock Inc. BLK | 5,849,917 5.800% | 1,037,610 (+21.56%) | Filing |
| 2025-04-28 5:45 pm Sale | 2025-03-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN | BlackRock Inc. BLK | 4,812,307 4.700% | -313,764 (-6.12%) | Filing |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN | BlackRock Inc. BLK | 5,126,071 5.900% | 5,126,071 (New Position) | Filing |